These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 808229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH, Nydegger UE, Zubler RH, Lambert PH, Miescher PA.
    Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH, Nydegger UE, Perrin LH, McCormic J, Fehr K, Miescher PA.
    Rheumatology; 1975 Mar; 6():52-9. PubMed ID: 1202608
    [Abstract] [Full Text] [Related]

  • 5. Activation of the complement and properdin systems in rheumatoid arthritis.
    Ruddy S, Austen KF.
    Ann N Y Acad Sci; 1975 Jun 13; 256():96-104. PubMed ID: 1099964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Behaviour of synovial complement C3 and C4 components in inflammatory and degenerative joint diseases, before and after synoviorthesis.
    Gabay R, Micheli A, Fallet GH.
    Ann Rheum Dis; 1975 Apr 13; 34(2):166-70. PubMed ID: 806271
    [Abstract] [Full Text] [Related]

  • 8. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
    Mellbye OJ, Naes B, Munthe E.
    Ann Rheum Dis; 1976 Jun 13; 35(3):233-9. PubMed ID: 825053
    [Abstract] [Full Text] [Related]

  • 9. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I, Nikolov K, Petrova P.
    Vutr Boles; 1987 Jun 13; 26(4):66-70. PubMed ID: 3499707
    [Abstract] [Full Text] [Related]

  • 10. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
    Mollnes TE, Lea T, Mellbye OJ, Pahle J, Grand O, Harboe M.
    Arthritis Rheum; 1986 Jun 13; 29(6):715-21. PubMed ID: 3718564
    [Abstract] [Full Text] [Related]

  • 11. Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis.
    Rynes RI, Ruddy S, Spragg J, Stillman JS, Austen KF.
    Arthritis Rheum; 1976 Jun 13; 19(2):161-8. PubMed ID: 1259792
    [Abstract] [Full Text] [Related]

  • 12. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A, Whaley K.
    J Rheumatol; 1980 Jun 13; 7(4):453-60. PubMed ID: 6158571
    [Abstract] [Full Text] [Related]

  • 13. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E, Nieuwland R, Tak PP, Pronk LM, Schaap MC, Sturk A, Hack CE.
    Ann Rheum Dis; 2007 Aug 13; 66(8):1085-92. PubMed ID: 17261534
    [Abstract] [Full Text] [Related]

  • 14. Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients.
    Munthe E, Hoyeraal HM, Froland SS, Mellbye OJ, Kåss E, Natvig JB.
    Rheumatology; 1975 Aug 13; 6():43-51. PubMed ID: 1081730
    [Abstract] [Full Text] [Related]

  • 15. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
    Lu-Steffes M, Iammartino AJ, Schmid FR, Castor CW, Davis L, Entwistle R, Anderson B.
    Ann Clin Lab Sci; 1982 Aug 13; 12(3):178-85. PubMed ID: 7092168
    [Abstract] [Full Text] [Related]

  • 16. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U, Merétey K, Falus A, Jancsó A, Bozsóky S.
    Allerg Immunol (Leipz); 1978 Aug 13; 24(3):167-74. PubMed ID: 152571
    [Abstract] [Full Text] [Related]

  • 17. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
    Perrin LH, Shiraishi S, Stroud RM, Lambert PH.
    J Immunol; 1975 Jul 13; 115(1):32-5. PubMed ID: 1171140
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of the immunological tests in rheumatoid arthritis.
    Kim NH, Yang KH, Yang IH.
    Yonsei Med J; 1989 Jul 13; 30(1):23-9. PubMed ID: 2741472
    [Abstract] [Full Text] [Related]

  • 19. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B.
    Z Rheumatol; 1981 Jul 13; 40(5):208-12. PubMed ID: 6914866
    [Abstract] [Full Text] [Related]

  • 20. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B.
    Z Rheumatol; 1976 Jul 13; 35(7-8):272-7. PubMed ID: 961078
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.